Appropriateness for SARS-CoV-2 vaccination for otolaryngologist and head and neck surgeons in case of pregnancy, breastfeeding, or childbearing potential: Yo-IFOS and CEORL-HNS joint clinical consensus statement.
Alberto Maria SaibeneFabiana AlleviTareck AyadTomislav BaudoinManuel Bernal-SprekelsenGiovanni BrigantiSean CarriePer Cayé-ThomasenSara Dahman SaidiNicolas DaubyJohn FentonWojciech GolusińskiLudger KlimekAndrée-Anne LeclercYves LongtinGiuditta MannelliMiguel Mayo YanezCem MecoOsama MetwalyFrançois MouawadKazimierz NiemczykUlrik PedersenKrzysztof PiersialaJan PlzákMarc RemacleNathalie RommelHesham SalehDawid SzpechtMiroslav TedlaCamilla TincatiManuel TucciaroneKarol ZelenikJérôme René LechienPublished in: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2021)
Until prospective evaluations on these topics are available, ORL-HNS must be considered a high infection risk specialty. While the use of PPE remains pivotal, ORL PBFHW should be allowed access to SARS-CoV-2 vaccination provided they receive up-to-date information.